Deep brain stimulation is a therapy that uses mild electrical pulses from an implanted device to stimulate the brain. The Deep Brain Stimulation for Parkinson’s Disease Media Kit includes news releases, backgrounders, illustrations, photography and animations.
Credit any images and video as follows: Images or video provided courtesy of St. Jude Medical, Inc.
| Images | Type |
|---|
|
 Photo - Athena™ Programmer (High Resolution)
St. Jude Medical, Inc., a global medical device company, has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
Medical image provided by St. Jude Medical, Inc. | JPG [764MB] |
|
Photo - Athena™ Programmer (Low Resolution)
St. Jude Medical, Inc., a global medical device company, has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
Medical image provided by St. Jude Medical, Inc. | JPG [71KB] |
|
 Photo - Athena™ Programmer Display (High Resolution)
St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
Medical image provided by St. Jude Medical, Inc. | JPG [1.67MB] |
|
Photo - Athena™ Programmer Display (Low Resolution)
St. Jude Medical, Inc., a global medical device company, has received European CE Mark approval of its new Athena™ programmer, a deep brain stimulation therapy management system. The easy-to-use programmer with the largest and only full-color touch screen allows clinicians to optimize deep brain stimulation therapy through advanced programming and data management features.
Medical image provided by St. Jude Medical, Inc. | JPG [128MB] |
 Photo - Libra™ DBS Systems Product Family (High Resolution)
Libra™ and LibraXP™ deep brain stimulation (DBS) systems are approved to treat the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech. | JPG [63KB] |
 Photo - Libra™ DBS Systems Product Family (Low Resolution)
See description for high resolution photo. | JPG [63KB] |
 Photo - Libra™ DBS System (High Resolution)
Libra DBS systems are approved to treat the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech. | JPG [449KB] |
 Photo - Libra™ DBS System (Low Resolution)
See description for high resolution photo. | JPG [60KB] |
 Photo - LibraXP™ DBS System (High Resolution)
LibraXP neurostimulators are constant current devices that feature the largest battery capacity of any DBS device in their class. They are approved to treat the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech. | JPG [414KB] |
 Photo - LibraXP™ DBS System (Low Resolution)
See description for high resolution photo. | JPG [58KB] |
 Illustration - LibraXP™ DBS System for Parkinson’s Disease (High Resolution)
Illustration of a male patient receiving deep brain stimulation for the management of the symptoms of Parkinson’s disease with the LibraXP deep brain stimulator. The device is typically implanted near the collarbone and sends mild electrical pulses to leads located in the brain. These mild pulses deliver electrical stimulation to a precisely targeted area in the brain. | JPG [1.8MB] |
 Illustration - LibraXP™ DBS system for Parkinson’s Disease (Low Resolution)
See description for high resolution photo. | JPG [185KB] |